Company Profile LogoMedGene Therapeutics

MedGene Therapeutics is a biotech company developing ACT treatments for two cancers using NIH patented technology.

Edit IconSuggest an Edit
Health Diagnostics
Health Care
Biotechnology

    Unlock insights on MedGene Therapeutics and 2M+ companies now!

    About MedGene Therapeutics

    MedGene Therapeutics is focused on developing ACT treatments (PMBC derived tumor-reactive T cells-Natural Unmodified CD8+ lymphocytes) for two cancers—MSTS (metastatic soft tissue sarcoma) and MFTC (metastatic follicular thyroid cancer)—using NIH patented technology with Worldwide Exclusive License Agreement of commercialization.

    Company Highlights
    Year Founded

    2015

    icon-altEmployees

    2

    Location (HQ)

    USA

    Since Last Funding

    3 years 2 months

    icon-altTotal Investment Amt

    $1.2M

    Last Funding Round

    Seed

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Health Care

    Biotechnology

    Health Diagnostics

    Biotechnology Research